Jason B. Daly is SVP, Chief Legal Officer of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of AMRX, which is worth approximately $0. The most recent transaction as insider was on Nov 21, 2024, when has been sold 13,665 shares (Class A Common Stock) at a price of $8.4 per share, resulting in proceeds of $114,786. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Jason B. Daly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
SELL
Open market or private sale
$114,786 $8.4 p/Share
13,665 Reduced 100.0%
0 Class A Common Stock
Nov 15 2024
SELL
Open market or private sale
$375,886 $8.61 p/Share
43,657 Reduced 76.16%
13,665 Class A Common Stock
Mar 03 2024
SELL
Payment of exercise price or tax liability
$98,624 $5.47 p/Share
18,030 Reduced 23.93%
57,322 Class A Common Stock
Mar 03 2024
BUY
Exercise of conversion of derivative security
-
60,871 Added 47.17%
68,186 Class A Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$15,674 $1.92 p/Share
8,164 Reduced 36.05%
14,481 Class A Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
-
22,645 Added 50.0%
22,645 Class A Common Stock
JBD

Jason B. Daly

SVP, Chief Legal Officer
Bridgewater, NJ

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX